Canada sours on its drug system just as Trump looks to import from it

Published



Just as the Trump administration is planning to let states import prescription drugs from Canada, the United States’s northern neighbors have grown impatient with their own high drug prices.

Canada is enmeshed in a drug pricing war. Canadians are paying among the highest prices in the world for drugs, prompting lawmakers to consider a major policy revamp, including the possibility of the government taking on more patient costs. Just as in the U.S., policymakers in Ottawa must contend with opposition from the pharmaceutical and insurance industries, negotiate with lower levels of government, and navigate deep political divisions.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.